HOMEProfessor Takeshi Tanaka

Faculty

Professor Takeshi Tanaka

Speciality / Research theme / Keywords
Clinical infectious diseases, Infection control and prevention, Control of vascular permeability, Tuberculosis, AMR(Antimicrobial resistance)
Supervision
Masters ProgrammeDoctoral Programme

Qualifications

MD, PhD

Personal/work Web page addresses

 http://www.tm.nagasaki-u.ac.jp/internal/

Research gate or Linked-in account links

https://www.researchgate.net/profile/Takeshi-Tanaka-8

Affiliation(s)

  • Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University/Department of Infectious Diseases, Nagasaki University Hospital.
  • The Japanese Society of Internal Medicine (Board Certified Member, Fellow).
  • The Japanese Association for Infectious Diseases (Board Certified Member, Senior)
  • The Japanese Respiratory Society (Board Certified Member, Senior Fellow).
  • The Japanese Society for AIDS Research.
  • The Japanese Society for infection Prevention and Control.
  • The Japanese Society of Chemotherapy.
  • The Japanese Society for Tuberculosis and Nontuberculosis Mycobacteriosis.
  • The Japan Society for Transplantation
  • American Thoracic Society.
  • Japanese Society of Tropical Medicine

Background

  • May 2002- May 2003: Resident, Department of Infectious and Respiratory Diseases, Nagasaki University Hospital, Nagasaki, Japan.
    The Japanese Society of Internal Medicine (Board Certified Member, Fellow).
  • June 2003- May 2004: Resident, Department of Internal Medicine, The Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
  • June 2004 – May 2005: Physician, Department of Respiratory Diseases, Juzenkai Hospital, Nagasaki, Japan.
  • June 2005 – March 2006: Physician, Department of Respiratory Diseases, Nagasaki Kawatana Medical Center, Nagasaki, Japan.
  • April 2006 – Sep 2011: ID and Chest Physician, Department of Infectious Diseases, Nagasaki University Hospital, Nagasaki, Japan.
  • Oct 2011-Sep 2013: Affiliate Researcher (Henson Lab), National Jewish Health, Colorado, USA.
  • Oct 2011-Sep 2013: Post-Doctoral Research Fellow (Vandivier Lab), Department of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Colorado,USA.
  • Oct 2013-March 2018 : Assistant Professor, Department of Infectious Diseases, Nagasaki University Hospital, Nagasaki, Japan.
  • April 2018-August 2020 : Senior Assistant Professor, Infection Control and Education Center, Nagasaki University Hospital, Nagasaki, Japan.
  • September 2020- September 2025: Associate Professor, Infection Control and Education Center, Nagasaki University Hospital, Nagasaki, Japan.

  • Sep 2025- : Professor, Department of Clinical Medicine, Clinical Medicine and Research Unit, Institute of Tropical Medicine, Nagasaki University/ Infectious Diseases Treatment and Prevention Center, Department of Infectious Diseases, Nagasaki University Hospital.

Teaching

Nagasaki University

  • Lecture on Infectious Diseases (3rd grade, School of Dentistry/4th grade, School of Pharmacy)
  • Lectures on Infectious Diseases (2nd and 3rd grade medical students)
    TMGH: MTM / Diploma /TTM: PPE (personal protection equipment) infection control practical session

Other

  • Member of Introduction and Training Team, member of Working Group for JICA, The Japan Disaster Relief Team (JDR), “Infectious Diseases Response Team”

Research

  • Tuberculosis
  • AMR(Antimicrobial resistance)
  • Vaccination Strategy for Immunocompromised Individuals in Japan
  • Control and regulation of vascular permeability in ARDS and septic shock.
  • Epidemiological research of opportunistic infections and malignancy in HIV/AIDS in Japan.

The country/countries where you work currently

Japan, Philippines, Mexico, Panama

Five MOST IMPORTANT/INTERESTING recent publications

  1. Tanaka T, Kakiuchi S, Fujita A, Tashiro M, Izumikawa K. Vaccination strategies for transplantation in Japan (solid organ transplantation and hematopoietic stem cell transplantation). J Infect Chemother. 2025; 31(9): 102772.
  2. Yasuda I, Saludar NRD, Sayo AR, Suzuki S, Yokoyama A, Ozeki Y, Kobayashi H, Nishiyama A, Matsumoto S, Cox SE, Tanaka T, Yamashita Y.  Evaluation of cytokine profiles related to Mycobacterium tuberculosis latent antigens using a whole-blood assay in the Philippines. Front Immunol. 2024; 15: 1330796.
  3. Tanaka T, Oshima K, Kawano K, Tashiro M, Kakiuchi S, Tanaka A, Fujita A, Ashizawa N, Tsukamoto M, Yasuoka A, Teruya K, Izumikawa K. Nationwide Longitudinal Annual Survey of HIV/AIDS Referral Hospitals in Japan From 1999-2021: Trend in Non-AIDS-Defining Cancers Among HIV-1-Infected Individuals. J Acquir Immune Defic Syndr. 2024; 96(1): 1-10.
  4. Tanaka T, Tashiro M, Ota K, Fujita A, Sawai T, Kadota J, Fukuda Y, Sumiyoshi M, Ide S, Tachikawa N, Fujii H, Hibino M, Shiomi H, Izumida M, Matsui K, Yamauchi M, Takahashi K, Yamanashi H, Sugimoto T, Akabame S, Umeda M, Shimizu M, Hosogaya N, Kosai K, Takeda K, Iwanaga N, Ashizawa N, Hirayama T, Takazono T, Yamamoto K, Imamura Y, Miyazaki T, Kobayashi Y, Ariyoshi K, Mukae H, Yanagihara K, Kita K, Izumikawa K. Safety and efficacy of 5-aminolevulinic acid phosphate/iron in mild-to-moderate coronavirus disease 2019: A randomized exploratory phase II trial. Medicine (Baltimore). 2023; 102(34): e34858.
  5. Tanaka T, Mori M, Sekino M, Higashijima U, Takaki M, Yamashita Y, Kakiuchi S, Tashiro M, Morimoto K, Tasaki O, Izumikawa K. Impact of plasma 5-hydroxyindoleacetic acid, a serotonin metabolite, on clinical outcome in septic shock, and its effect on vascular permeability. Sci Rep. 2021; 11(1): 14146.

Other Achievements：https://researchmap.jp/ttakeshi

Message

Infectious disease specialists must address a wide range of issues. I hold joint appointments at the Institute of Tropical Medicine and Nagasaki University Hospital. At the Institute, my work in the field of clinical infectious diseases focuses on research conducted in overseas settings, targeting tuberculosis, antimicrobial resistance (AMR), and other infectious diseases. At the university hospital, I am involved in the management of severe infections, including.

PAGE TOP